Arginine-vasopressin as a rescue therapy in children with cardiocirculatory failure [1]

Critical Care Medicine

Volumn 35, Issue 7, 2007, Pages 1800-

  Meyer, Sascha ^a   Gottschling, Sven ^b   Gortner, Ludwig ^b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b SAARLAND UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN; CATECHOLAMINE; VASOCONSTRICTOR AGENT;

ARTERIAL PRESSURE; CARDIOGENIC SHOCK; CIRCULATION; DRUG TREATMENT FAILURE; HEART MUSCLE ISCHEMIA; HUMAN; LETTER; PRIORITY JOURNAL; RESUSCITATION; SEPTIC SHOCK; CHILD; METHODOLOGY; PATIENT SELECTION; SALVAGE THERAPY;

ARGININE VASOPRESSIN; CARDIOPULMONARY RESUSCITATION; CHILD; HUMANS; PATIENT SELECTION; SALVAGE THERAPY; VASOCONSTRICTOR AGENTS;

EID: 34250888724     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000269405.18646.52     Document Type: Letter

References (5)

1. Matok I, Vardi A, Augarten A, et al: Beneficial effects of terlipresssin in prolonged resuscitation: A case series. Crit Care Med 2007; 35:1-4
2. Landry DW, Levin HR, Gallant EM, et al: Vasopressin deficiency contributes to the vasodilatation of septic shock. Circulation 1997; 95:1122-1125
3. Liedel JL, Meadow W, Nachman J, et al: Use of vasopressin in refractory hypotension in children with vasodilatatory shock: Five cases and a review of the literature. Pediatr Crit Care Med 2002; 3:15-18
4. Masutani S, Senzaki H, Ishido H, et al: Vasopressin in the treatment of vasodilatory shock in children. Pediatr Int 2005; 47:132-136
5. Meyer S, Gottschling S, Baghai A, et al: Arginine-vasopressin in catecholamine-refractory septic and non-septic shock in extremely low birth weight infants with acute renal injury. Crit Care 2006; 10:R71-R76